Protein Design and Engineering Market Global Report 2026

The protein design and engineering market size has grown rapidly in recent years. It will grow from $7.62 billion in 2025 to $8.79 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to progress in molecular biology methodologies, rising investment in pharmaceutical research and development, expanding use of recombinant DNA technologies, growth in structural biology research tools, and increasing demand for advanced biologics and vaccines.

The protein design and engineering market size is expected to see rapid growth in the next few years. It will grow to $15.71 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth over the forecast period can be attributed to rapid expansion of AI-powered drug discovery platforms, increasing demand for individualized and precision-based therapeutics, wider adoption of synthetic biology applications across life sciences, growing investment in precision medicine research initiatives, and rising use of high-performance computing systems for advanced protein modeling. Major trends during the forecast period include increasing adoption of AI-driven protein structure prediction platforms to accelerate drug discovery processes, growing use of computational modeling techniques for designing novel enzymes with enhanced catalytic performance, rising demand for de novo protein engineering approaches in therapeutic development, expansion of synthetic biology methods for development of customized biologics and biomaterials, and increasing integration of high-throughput screening technologies in protein optimization and development workflows.

The increasing focus on biologics is expected to propel the growth of the protein design and engineering market going forward. Biologics are therapeutic products derived from living organisms or their components that target specific pathways in the immune system to treat diseases. The emphasis on biologics is growing due to advancements in biotechnology and immunology, which have enabled the development of more precise and effective treatments that target the underlying mechanisms of immune-mediated conditions rather than merely managing symptoms. Protein design and engineering enhances biologics by enabling the precise creation and optimization of therapeutic proteins with improved stability, efficacy, and target specificity, thereby accelerating the development of safer and more effective biologic drugs. For instance, in February 2025, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the 2023 WHO Essential Medicines List includes 81 biologic therapies, representing over 15% of all listed medicines. Therefore, the increasing focus on biologics is driving the growth of the protein design and engineering market.

Key companies operating in the protein design and engineering market are focusing on developing innovative solutions, such as biological AI foundation models to accelerate the design of novel proteins, improve prediction of structure function relationships, and speed up drug discovery and bioengineering applications. A biological AI foundation model is a large-scale artificial intelligence system trained on vast biological data (such as DNA, RNA, and protein sequences) that can learn general biological patterns and can be adapted to perform tasks like protein design, structure prediction, and drug discovery. For example, in June 2024, EvolutionaryScale PBC, a US-based artificial intelligence biotechnology company, launched ESM3, an AI model capable of generating novel proteins to accelerate drug discovery, protein design, and biological research. The model leverages advanced generative AI to design and generate novel protein sequences with desired structures and functions. It is positioned as a technology-driven solution to accelerate protein discovery, enabling researchers to create entirely new proteins more efficiently. The platform supports streamlined protein engineering workflows by integrating sequence generation with structural prediction, reflecting the company’s focus on advancing AI-driven biological design.

In June 2024, Johnson & Johnson, a US-based healthcare corporation, completed the acquisition of Proteologix for $850 million. Through this transaction, Johnson & Johnson seeks to enhance its portfolio of engineered biologics and broaden its expertise in next-generation bispecific antibody therapies targeting immune-mediated disorders. Proteologix Inc. is a US-based company focused on the development of biologics through advanced protein engineering approaches.

Major companies operating in the protein design and engineering market are Merck KGaA, Eurofins Scientific SE, Lonza Group AG, DeepMind Technologies Limited, GenScript Biotech Corporation, Twist Bioscience Corporation, Ginkgo Bioworks Holdings Inc., Schrödinger Inc., Codexis Inc., Isomorphic Labs Limited, Generate Biomedicines Inc., Absci Corporation, Insilico Medicine Inc., EvolutionaryScale Inc., Latent Labs Inc., Telesis Bio Inc., Synbio Technologies LLC, Cradle Bio B.V., Arzeda Corporation, ProteinQure Inc., A-Alpha Bio Inc., DenovAI Biotech GmbH, Innophore GmbH.

North America was the dominant region in the protein design and engineering market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in protein design and engineering report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein design and engineering market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The protein design and engineering market includes revenues earned by entities by providing services such as protein design using computational modeling, protein synthesis, expression services, and therapeutic protein development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The protein design and engineering market research report is one of a series of new reports that provides protein design and engineering market statistics, including protein design and engineering industry global market size, regional shares, competitors with a protein design and engineering market share, detailed protein design and engineering market segments, market trends and opportunities, and any further data you may need to thrive in the protein design and engineering industry. This protein design and engineering market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.